Financials PT Prodia Widyahusada Tbk

Equities

End-of-day quote INDONESIA S.E. Other stock markets 03:30:00 13/05/2024 am IST			5-day change	1st Jan Change
3,000 ^IDR	-3.23%		-7.12%	-44.44%

30/04	PT Prodia Widyahusada Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
08/03	PT Prodia Widyahusada Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	33,93,750	30,46,875	86,25,000	52,50,000	50,62,500	28,12,500	-	-
Enterprise Value (EV) ²	3,394	1,956	7,150	4,083	5,062	1,873	1,860	2,812
P/E ratio	16.1 x	11.3 x	13.9 x	14.2 x	19.5 x	7.66 x	7.56 x	-
Yield	3.1%	3.45%	1.87%	7.1%	-	6.92%	8.62%	-
Capitalization / Revenue	1.95 x	1.63 x	3.25 x	2.41 x	2.28 x	1.2 x	1.07 x	-
EV / Revenue	1.95 x	1.04 x	2.7 x	1.87 x	2.28 x	0.8 x	0.71 x	-
EV / EBITDA	12 x	5.3 x	8.69 x	7.96 x	10.7 x	3.37 x	2.79 x	-
EV / FCF	-	6.5 x	10.6 x	12.5 x	-	8.14 x	6.35 x	8.55 x
FCF Yield	-	15.4%	9.41%	7.98%	-	12.3%	15.7%	11.7%
Price to Book	2.04 x	1.7 x	3.83 x	2.27 x	-	1.13 x	1.04 x	-
Nbr of stocks (in thousands)	9,37,500	9,37,500	9,37,500	9,37,500	9,37,500	9,37,500	-	-
Reference price ³	3,620	3,250	9,200	5,600	5,400	3,000	3,000	3,000
Announcement Date	10/03/20	12/03/21	15/03/22	15/03/23	08/03/24	-	-	-

¹IDR in Million²IDR in Billions³IDR

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	1,744	1,873	2,652	2,182	2,222	2,347	2,632	-
EBITDA ¹	283.2	369.3	822.6	513.1	474.6	556.4	665.9	-
EBIT ¹	216	301.8	756.6	447	299.1	423.6	483.8	-
Operating Margin	12.39%	16.11%	28.53%	20.49%	13.46%	18.05%	18.38%	-
Earnings before Tax (EBT) ¹	264.8	339.1	786.6	470.3	338.9	468	474	-
Net income ¹	210.3	268.7	621.6	371.6	259.9	367	372	-
Net margin	12.05%	14.35%	23.44%	17.04%	11.69%	15.64%	14.13%	-
EPS ²	224.3	286.7	663.1	394.9	277.2	391.8	397.0	-
Free Cash Flow ³	-	3,01,134	6,73,159	3,25,985	-	2,30,000	2,93,000	3,29,000
FCF margin	-	16,074.41%	25,380.61%	14,942.19%	-	9,800.98%	11,133.01%	-
FCF Conversion (EBITDA)	-	81,533.23%	81,830.9%	63,538.52%	-	41,336.72%	44,003.27%	-
FCF Conversion (Net income)	-	1,12,051.11%	1,08,290.56%	87,713.61%	-	62,670.3%	78,763.44%	-
Dividend per Share ²	112.1	112.1	172.0	397.8	-	207.7	258.7	-
Announcement Date	10/03/20	12/03/21	15/03/22	15/03/23	08/03/24	-	-	-

¹IDR in Billions²IDR³IDR in Million

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	-	-	-	-	-	-	-
Net Cash position ¹	-	1,091	1,475	1,167	-	940	952	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Free Cash Flow ²	-	3,01,134	6,73,159	3,25,985	-	2,30,000	2,93,000	3,29,000
ROE (net income / shareholders' equity)	13.1%	13.5%	30.8%	16.1%	-	14.6%	15.4%	-
ROA (Net income/ Total Assets)	-	12%	25.1%	13.8%	-	12.8%	12.2%	-
Assets ¹	-	2,240	2,475	2,686	-	2,867	3,049	-
Book Value Per Share ³	1,770	1,908	2,402	2,462	-	2,665	2,886	-
Cash Flow per Share ³	-	464.0	829.0	459.0	-	518.0	553.0	-
Capex ¹	-	133	104	134	-	266	255	-
Capex / Sales	-	7.13%	3.93%	6.13%	-	11.34%	9.69%	-
Announcement Date	10/03/20	12/03/21	15/03/22	15/03/23	08/03/24	-	-	-

¹IDR in Billions²IDR in Million³IDR

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3,000 IDR

Average target price

6,233 IDR

Spread / Average Target

+107.78%

	1st Jan change	Capi.
PT PRODIA WIDYAHUSADA TBK	-44.44%	18Cr
SONIC HEALTHCARE LIMITED	-15.77%	848.84Cr
RADNET, INC.	+60.25%	408.19Cr
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-43.01%	242.38Cr
SYNLAB AG	-9.98%	242.38Cr
DR. LAL PATHLABS LIMITED	-3.24%	233.43Cr
NEOGENOMICS, INC.	-3.40%	201.4Cr
FLEURY S.A.	-19.79%	152.85Cr
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.57%	125.94Cr
METROPOLIS HEALTHCARE LIMITED	+9.11%	107.19Cr